Pulse Biosciences, Inc. PLSE Operating Income
Discontinued — last reported Q1 '26
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s operating income?
- Pulse Biosciences, Inc. (PLSE) reported operating income of -$19.15M in Q1 2026.
- How has Pulse Biosciences, Inc.'s operating income changed year-over-year?
- Pulse Biosciences, Inc.'s operating income decreased by 6.1% year-over-year, from -$18.04M to -$19.15M.
- What is the long-term trend for Pulse Biosciences, Inc.'s operating income?
- Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s operating income has grown at a 5.1% compound annual growth rate (CAGR), from -$63.01M to -$76.94M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.